| Message : | Could I ask who's calling? http://centralroofers.co.uk/stmap_e4790.html?cyproheptadine.isosorbide.cialis skyrim bodychange.esp "We believe Mylan is a business capable of generating low double digit bottom line growth over the next several years, aided by a mix of bolt-on acquisitions and share repurchases," J.P. Morgan analyst Chris Schott said in a research note.
***---REPLIED TO MESSAGE BELOW---***
Could I ask who's calling? http://centralroofers.co.uk/stmap_e4790.html?cyproheptadine.isosorbide.cialis skyrim bodychange.esp "We believe Mylan is a business capable of generating low double digit bottom line growth over the next several years, aided by a mix of bolt-on acquisitions and share repurchases," J.P. Morgan analyst Chris Schott said in a research note.
|